{"id":515480,"date":"2021-07-21T06:28:15","date_gmt":"2021-07-21T10:28:15","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/johnson-johnson-reports-q2-2021-results\/"},"modified":"2021-07-21T06:28:15","modified_gmt":"2021-07-21T10:28:15","slug":"johnson-johnson-reports-q2-2021-results","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/johnson-johnson-reports-q2-2021-results\/","title":{"rendered":"Johnson & Johnson Reports Q2 2021 Results"},"content":{"rendered":"
\n

– Strong sales growth of 27.1% to $23.3 Billion in Second Quarter 2021 with operational growth of 23.0%* and adjusted operational growth of 23.8%*<\/h2>\n

– EPS of $2.35 increased 72.8% in Second Quarter 2021 and adjusted EPS of $2.48 increased 48.5%*<\/h2>\n

– Company increasing 2021 Full-Year guidance for sales and EPS<\/h2>\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n NEW BRUNSWICK, N.J.<\/span>, July 21, 2021<\/span> \/PRNewswire\/ —\u00a0Johnson & Johnson (NYSE: JNJ) today announced results for second-quarter. “Our second-quarter results showcase Johnson & Johnson’s diversified portfolio, driven by strong sales and earnings growth across our Medical Device, Consumer Health and Pharmaceutical businesses,” said Alex Gorsky<\/span>, Chairman and Chief Executive Officer. “I’m so proud of our 136,000 colleagues who remain focused on delivering our medicines and products to patients and consumers around the world, in addition to advancing our pipeline with new product launches and regulatory submissions. These accomplishments exemplify our commitment to advancing transformational innovations that improve the health of people and communities everywhere while continuing to deliver long-term value to all of our stakeholders.”<\/p>\n

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

\n
\n
\n OVERALL FINANCIAL RESULTS<\/u>
\n <\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n Q2<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n ($ in Millions, except EPS)<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 2021<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 2020<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n %\u00a0 Change<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Reported Sales<\/span>\n <\/p>\n<\/td>\n

\n

\n $ \u00a0 \u00a0 \u00a0 23,312<\/span>\n <\/p>\n<\/td>\n

\n

\n $ \u00a0 \u00a0 \u00a0 18,336<\/span>\n <\/p>\n<\/td>\n

\n

\n 27.1%<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Net Earnings<\/span>\n <\/p>\n<\/td>\n

\n

\n 6,278<\/span>\n <\/p>\n<\/td>\n

\n

\n 3,626<\/span>\n <\/p>\n<\/td>\n

\n

\n 73.1<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n EPS (diluted)<\/span>\n <\/p>\n<\/td>\n

\n

\n $ \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 2.35<\/span>\n <\/p>\n<\/td>\n

\n

\n $ \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 1.36<\/span>\n <\/p>\n<\/td>\n

\n

\n 72.8%<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n Q2<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n
\n Non-GAAP*<\/b>
\n ($ in Millions, except EPS)<\/b>
\n <\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 2021<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 2020<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n %\u00a0 Change<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Operational Sales1,2<\/sup><\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n

\n 23.0%<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Adjusted Operational Sales1,3<\/sup><\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n

\n 23.8<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Adjusted Net Earnings1,4<\/sup><\/span>\n <\/p>\n<\/td>\n

\n

\n 6,625<\/span>\n <\/p>\n<\/td>\n

\n

\n 4,446<\/span>\n <\/p>\n<\/td>\n

\n

\n 49.0<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Adjusted EPS (diluted)1,4<\/sup><\/span>\n <\/p>\n<\/td>\n

\n

\n $ \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 2.48<\/span>\n <\/p>\n<\/td>\n

\n

\n $ \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 1.67<\/span>\n <\/p>\n<\/td>\n

\n

\n 48.5%<\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

\n\n\n\n\n\n\n
\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n 1<\/sup>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n Non-GAAP financial measure;\u00a0refer to reconciliations of non-GAAP financial measures included in accompanying schedules\u00a0 <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n 2<\/sup>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n Excludes the impact of translational currency<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n 3<\/sup>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n Excludes the net impact of acquisitions and divestitures and translational currency<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n 4<\/sup>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n Excludes intangible amortization expense and special items<\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

\u00a0<\/p>\n

\n\n\n\n\n\n\n\n\n
\n

\n
\n
\n REGIONAL SALES RESULTS<\/u>
\n <\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n Q2<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n %\u00a0 Change<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n ($ in Millions)<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 2021<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 2020<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n Reported<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n Operational1,2<\/sup><\/b><\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n Currency<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n Adjusted
Operational1,3<\/sup><\/b><\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n U.S.<\/span>\n <\/p>\n<\/td>\n

\n

\n $ \u00a0 \u00a0 \u00a011,919<\/span>\n <\/p>\n<\/td>\n

\n

\n $ \u00a0 \u00a0 \u00a0 \u00a09,539<\/span>\n <\/p>\n<\/td>\n

\n

\n 24.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 24.9<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n

\n 25.1<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n International<\/span>\n <\/p>\n<\/td>\n

\n

\n 11,393<\/span>\n <\/p>\n<\/td>\n

\n

\n 8,797<\/span>\n <\/p>\n<\/td>\n

\n

\n 29.5<\/span>\n <\/p>\n<\/td>\n

\n

\n 20.9<\/span>\n <\/p>\n<\/td>\n

\n

\n 8.6<\/span>\n <\/p>\n<\/td>\n

\n

\n 22.4<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Worldwide<\/span>\n <\/p>\n<\/td>\n

\n

\n $ \u00a0 \u00a0 \u00a023,312<\/span>\n <\/p>\n<\/td>\n

\n

\n $ \u00a0 \u00a0 \u00a018,336<\/span>\n <\/p>\n<\/td>\n

\n

\n 27.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 23.0<\/span>\n <\/p>\n<\/td>\n

\n

\n 4.1<\/span>\n <\/p>\n<\/td>\n

\n

\n 23.8<\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

\n\n\n\n\n\n\n
\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n 1<\/sup>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n Non-GAAP financial measure; refer to reconciliations of non-GAAP financial measures included in accompanying schedules<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n 2<\/sup>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n Excludes the impact of translational currency<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n 3<\/sup>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n Excludes the net impact of acquisitions and divestitures and translational currency<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n

\n Note: values may have been rounded<\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

\u00a0<\/p>\n

\n\n\n\n\n\n\n\n\n\n
\n

\n
\n
\n SEGMENT SALES RESULTS<\/u>
\n <\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n Q2<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n %\u00a0 Change<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n ($ in Millions)<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 2021<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 2020<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n Reported<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n Operational1,2<\/sup><\/b><\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n Currency<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n Adjusted
Operational1,3<\/sup><\/b><\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Consumer Health<\/span>\n <\/p>\n<\/td>\n

\n

\n $ \u00a0 \u00a0 \u00a0 \u00a03,735<\/span>\n <\/p>\n<\/td>\n

\n

\n $ \u00a0 \u00a0 \u00a0 \u00a03,296<\/span>\n <\/p>\n<\/td>\n

\n

\n 13.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 9.2<\/span>\n <\/p>\n<\/td>\n

\n

\n 4.1<\/span>\n <\/p>\n<\/td>\n

\n

\n 10.0<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Pharmaceutical<\/span>\n <\/p>\n<\/td>\n

\n

\n 12,599<\/span>\n <\/p>\n<\/td>\n

\n

\n 10,752<\/span>\n <\/p>\n<\/td>\n

\n

\n 17.2<\/span>\n <\/p>\n<\/td>\n

\n

\n 13.6<\/span>\n <\/p>\n<\/td>\n

\n

\n 3.6<\/span>\n <\/p>\n<\/td>\n

\n

\n 14.1<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Medical Devices<\/span>\n <\/p>\n<\/td>\n

\n

\n 6,978<\/span>\n <\/p>\n<\/td>\n

\n

\n 4,288<\/span>\n <\/p>\n<\/td>\n

\n

\n 62.7<\/span>\n <\/p>\n<\/td>\n

\n

\n 57.2<\/span>\n <\/p>\n<\/td>\n

\n

\n 5.5<\/span>\n <\/p>\n<\/td>\n

\n

\n 58.7<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Worldwide<\/span>\n <\/p>\n<\/td>\n

\n

\n $ \u00a0 \u00a0 \u00a023,312<\/span>\n <\/p>\n<\/td>\n

\n

\n $ \u00a0 \u00a0 \u00a018,336<\/span>\n <\/p>\n<\/td>\n

\n

\n 27.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 23.0<\/span>\n <\/p>\n<\/td>\n

\n

\n 4.1<\/span>\n <\/p>\n<\/td>\n

\n

\n 23.8<\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

\n\n\n\n\n\n\n
\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n 1<\/sup>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n Non-GAAP financial measure; refer to reconciliations of non-GAAP financial measures included in accompanying schedules<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n 2<\/sup>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n Excludes the impact of translational currency<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n 3<\/sup>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n Excludes the net impact of acquisitions and divestitures and translational currency<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n

\n Note: values may have been rounded<\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

\n
\n Second Quarter 2021 SEGMENT COMMENTARY:<\/u>
\n <\/b>\u00a0 <\/p>\n

\n
\n Consumer Health
<\/u>
\n <\/b>Consumer Health worldwide operational sales, excluding the net impact of acquisitions and divestitures, increased 10.0%* inclusive of the market recovery from COVID-19 impacts, primarily in skin health\/beauty.\u00a0 Sales growth was driven by skin health\/beauty products including NEUTROGENA, AVEENO, and OGX; over-the-counter products including ZYRTEC in upper respiratory products, international analgesics, and digestive health products; and BAND-AID\u00ae<\/sup> Brand Adhesive Bandages in wound care products.\u00a0 <\/p>\n

\n
\n Pharmaceutical
<\/u>
\n <\/b>Pharmaceutical worldwide operational sales, excluding the net impact of acquisitions and divestitures, grew 14.1%* driven by STELARA (ustekinumab), a biologic for the treatment of a number of immune-mediated inflammatory diseases, DARZALEX (daratumumab), for the treatment of multiple myeloma, TREMFYA (guselkumab), a biologic for the treatment of adults living with moderate to severe plaque psoriasis, and for adults with active psoriatic arthritis, ERLEADA (apalutamide), a next-generation androgen receptor inhibitor for the treatment of patients with prostate cancer, IMBRUVICA (ibrutinib), an oral, once-daily therapy approved for use in treating certain B-cell malignancies, a type of blood or lymph node cancer, and INVEGA SUSTENNA\/XEPLION\/INVEGA TRINZA\/TREVICTA (paliperidone palmitate), long-acting, injectable atypical antipsychotics for the treatment of schizophrenia in adults. This growth was partially offset by biosimilar and generic competition, with declines primarily in REMICADE (infliximab), a biologic approved for the treatment of a number of immune-mediated inflammatory diseases.<\/p>\n

\n
\n Medical Devices
<\/u>
\n <\/b>Medical Devices worldwide operational sales, excluding the net impact of acquisitions and divestitures, grew 58.7%*, primarily driven by the benefit of market recovery from COVID-19 impacts and the associated deferral of medical procedures in the prior year across all of our businesses\u00a0including Surgery, Orthopaedics, Vision and Interventional Solutions. <\/p>\n

\n
\n NOTABLE NEW ANNOUCEMENTS IN THE QUARTER:
<\/u>
\n <\/b>The information contained in this section should be read in conjunction with Johnson & Johnson’s other disclosures filed with the Securities and Exchange Commission, including its Current Reports on Form 8-K, Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K. Copies of these filings are available online at www.sec.gov<\/a>, www.jnj.com<\/a>\u00a0or on request from Johnson & Johnson. The reader is also encouraged to review all other news releases available online in the Investors section of the company’s website at news releases<\/a>.<\/p>\n

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

\n Regulatory
Decisions<\/span>\n <\/p>\n<\/td>\n

\n

\n TECNIS SYNERGY and TECNIS SYNERGY TORIC II IOLS a Next Generation Treatment for Cataract Patients Received Regulatory Approval and Launched in the U.S. and Canada<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n (press release)<\/a>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n (press release)<\/a>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n RYBREVANT (amivantamab-vmjw) Receives U.S. FDA Approval as the First Targeted Treatment for Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n (press release)<\/a>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n PONVORY (ponesimod) receives European Commission approval for the Treatment of Adults with Relapsing Forms of Multiple Sclerosis with Active Disease Defined by Clinical or Imaging Features<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n (press release)<\/a>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n DARZALEX (daratumumab) Subcutaneous (SC) Formulation Becomes the First Approved Treatment for Newly Diagnosed Systemic Light Chain Amyloidosis in Europe and Gains an Additional Approval in Pre-Treated Multiple Myeloma<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n (press release)<\/a>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) Receives U.S. FDA Approval for Combination with Pomalidomide and Dexamethasone for Patients with Multiple Myeloma After First or Subsequent Relapse1<\/sup><\/span>\n <\/p>\n<\/td>\n

\n

\n
\n (press release)<\/a>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Regulatory
Submissions<\/span>\n <\/p>\n<\/td>\n

\n

\n Janssen granted Breakthrough Therapy Designation from the U.S. FDA for Teclistamab for the Treatment of Relapsed or Refractory Multiple Myeloma<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n (press release)<\/a>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Janssen Submits Marketing Authorisation Application to the European Medicines Agency for BCMA CAR-T Therapy Ciltacabtagene Autoleucel (cilta-cel) for the Treatment of Relapsed and\/or Refractory Multiple Myeloma<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n (press release)<\/a>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Janssen Submits New Drug Application to U.S. FDA for XARELTO (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n (press release)<\/a>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Other<\/span>\n <\/p>\n<\/td>\n

\n

\n Johnson & Johnson Joins World Health Organization in Efforts to Prevent Spread of Ebola in West Africa<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n (press release)<\/a>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Janssen Discontinues Collaboration and License Agreement with argenx for Cusatuzumab<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n (press release)<\/a>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n ETHICON expands Advanced Bipolar Energy Portfolio with Launch of ENSEAL X1 Curved Jaw Tissue Sealer<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n (press release)<\/a>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Johnson & Johnson Announces Positive New Data for the Single-Shot COVID-19 Vaccine on Activity Against Delta Variant and Long-lasting Durability of Response<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n (press release)<\/a>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Johnson & Johnson Consumer Inc. Issues Voluntary Recall of Specific NEUTROGENA and AVEENO Aerosol Sunscreen Products Due to the Presence of Benzene1<\/sup><\/span>\n <\/p>\n<\/td>\n

\n

\n
\n (press release)<\/a>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n 1<\/sup>Subsequent to the quarter <\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

<\/p>\n

\n
\n FULL-YEAR 2021 GUIDANCE:
<\/u>
\n <\/b>Johnson & Johnson does not provide GAAP financial measures on a forward-looking basis because the company is unable to predict with reasonable certainty the ultimate outcome of legal proceedings, unusual gains and losses, acquisition-related expenses and purchase accounting fair value adjustments without unreasonable effort. These items are uncertain, depend on various factors, and could be material to Johnson & Johnson’s results computed in accordance with GAAP.<\/p>\n

\n\n\n\n\n\n\n\n\n
\n

\n ($ in Billions, except EPS)<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n April 2021\u00a0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n July 2021 (Base Business)<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n July 2021 (incl. COVID Vx)<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Adjusted Operational Sales1,2<\/sup><\/span>\n <\/p>\n

\n Change vs. Prior Year<\/span>\n <\/p>\n<\/td>\n

\n

\n 8.7% – 9.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 9.5% – 10.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 12.5% – 13.5%<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Operational Sales2<\/sup><\/span>\n <\/p>\n

\n Change vs. Prior Year<\/span>\n <\/p>\n<\/td>\n

\n

\n $89.3B – $90.3B<\/span>\n <\/p>\n

\n 8.2% \u2013 9.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n $90.0B – $90.8B<\/span>\n <\/p>\n

\n 9.0% \u2013 10.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n $92.5B – $93.3B<\/span>\n <\/p>\n

\n 12.0% \u2013 13.0%<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Estimated Reported Sales3<\/sup><\/span>\n <\/p>\n

\n Change vs. Prior Year<\/span>\n <\/p>\n<\/td>\n

\n

\n $90.6B – $91.6B<\/span>\n <\/p>\n

\n 9.7% \u2013 10.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n $91.3B – $92.1B<\/span>\n <\/p>\n

\n 10.5% \u2013 11.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n $93.8B – $94.6B<\/span>\n <\/p>\n

\n 13.5% \u2013 14.5%<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n Adjusted Operational EPS
(Diluted)2,4<\/sup><\/span>\n <\/p>\n

\n Change vs. Prior Year<\/span>\n <\/p>\n<\/td>\n

\n

\n $9.30 – $9.45<\/span>\n <\/p>\n

\n 15.8% – 17.7%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n $9.50 – $9.60<\/span>\n <\/p>\n

\n 18.4% – 19.6%<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Adjusted EPS (Diluted)3,4<\/sup><\/span>\n <\/p>\n

\n Change vs. Prior Year<\/span>\n <\/p>\n<\/td>\n

\n

\n $9.42 – $9.57<\/span>\n <\/p>\n

\n 17.3% – 19.2%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n $9.60 – $9.70<\/span>\n <\/p>\n

\n 19.6% – 20.8%<\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

\n\n\n\n\n\n\n\n
\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n 1<\/sup>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n Non-GAAP financial measure; excludes the net impact of acquisitions and divestitures<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n 2<\/sup>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n Non-GAAP financial measure; excludes the impact of translational currency<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n 3<\/sup>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n Calculated using Euro Average Rate: April 2021 = $1.19 and July 2021 = $1.19 (Illustrative purposes only)<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n 4<\/sup>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n Non-GAAP financial measure; excludes intangible amortization expense and special items<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n

\n Note: % may have been rounded<\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

Other modeling considerations will be provided on the webcast<\/a>.<\/p>\n

\n
\n WEBCAST INFORMATION:
<\/u>
\n <\/b>Johnson & Johnson will conduct a conference call with investors to discuss this earnings release today at 8:30 a.m., Eastern Time<\/span>. A simultaneous webcast of the call for investors and other interested parties may be accessed by visiting the Johnson & Johnson website<\/a>. A replay and podcast will be available approximately two hours after the live webcast in the Investors section of the company’s website at events-and-presentations<\/a>.\u00a0 <\/p>\n

\n
\n ABOUT JOHNSON & JOHNSON:
<\/u>
\n <\/b>At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most broadly-based health care company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.<\/p>\n

\n
\n NON-GAAP FINANCIAL MEASURES:
<\/u>
\n <\/b>*Operational sales growth excluding the impact of translational currency, adjusted operational sales growth excluding the net impact of acquisitions and divestitures and translational currency, as well as adjusted net earnings, adjusted diluted earnings per share and adjusted operational diluted earnings per share excluding after-tax intangible amortization expense and special items, are non-GAAP financial measures and should not be considered replacements for, and should be read together with, the most comparable GAAP financial measures. Except for guidance measures, reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures can be found in the accompanying financial schedules of the earnings release and the Investors section of the company’s website at quarterly-results<\/a>. <\/p>\n

Copies of the financial schedules accompanying this earnings release are available on the company’s website at quarterly-results<\/a>. These schedules include supplementary sales data, a condensed consolidated statement of earnings, reconciliations of non-GAAP financial measures, and sales of key products\/franchises. Additional information on Johnson & Johnson, including adjusted income before tax by segment, a pharmaceutical pipeline<\/a> of selected compounds in late stage development and a copy of today’s earnings call presentation can also be found in the Investors section of the company’s website at quarterly-results<\/a>.<\/p>\n

\n
\n NOTE TO INVESTORS CONCERNING FORWARD-LOOKING STATEMENTS:
<\/u>
\n <\/b>This press release contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things: future operating and financial performance, product development, market position and business strategy. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Johnson & Johnson. Risks and uncertainties include, but are not limited to: risks related to the impact of the COVID-19 global pandemic, such as the scope and duration of the outbreak, government actions and restrictive measures implemented in response, material delays and cancellations of medical procedures, supply chain disruptions and other impacts to the business, or on the Company’s ability to execute business continuity plans, as a result of the COVID-19 pandemic, economic factors, such as interest rate and currency exchange rate fluctuations; competition, including technological advances, new products and patents attained by competitors; challenges inherent in new product research and development, including uncertainty of clinical success and obtaining regulatory approvals; uncertainty of commercial success for new and existing products; challenges to patents; the impact of patent expirations; the ability of the Company to successfully execute strategic plans; the impact of business combinations and divestitures; manufacturing difficulties or delays, internally or within the supply chain; product efficacy or safety concerns resulting in product recalls or regulatory action; significant adverse litigation or government action, including related to product liability claims; changes to applicable laws and regulations, including tax laws and global health care reforms; trends toward health care cost containment; changes in behavior and spending patterns of purchasers of health care products and services; financial instability of international economies and legal systems and sovereign risk; increased scrutiny of the health care industry by government agencies. A further list and descriptions of these risks, uncertainties and other factors can be found in Johnson & Johnson’s Annual Report on Form 10-K for the fiscal year ended January 3, 2021<\/span> including in the sections captioned “Cautionary Note Regarding Forward-Looking Statements” and “Item 1A. Risk Factors,” in the Company’s most recently filed Quarterly Report on Form 10-Q and the Company’s subsequent filings with the Securities and Exchange Commission. Copies of these filings are available online at www.sec.gov<\/a>, www.jnj.com<\/a> or on request from Johnson & Johnson. Any forward-looking statement made in this release speaks only as of the date of this release. Johnson & Johnson does not undertake to update any forward-looking statement as a result of new information or future events or developments.<\/p>\n

\u00a0<\/p>\n

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

\n
\n Johnson & Johnson and Subsidiaries<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n Supplementary Sales Data<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n (Unaudited; Dollars in Millions)<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n SECOND QUARTER<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n SIX MONTHS<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n \u00a0Percent Change<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n Percent Change<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n

\n
\n 2021<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 2020<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n Total<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n Operations<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n Currency<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 2021<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 2020<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n Total<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n Operations<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n Currency<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Sales to customers by<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n segment of business<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n Consumer Health<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n \u00a0\u00a0\u00a0 U.S.<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n $ \u00a0 1,751<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,557<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 12.4<\/span>\n <\/p>\n<\/td>\n

\n

\n %<\/span>\n <\/p>\n<\/td>\n

\n

\n 12.4<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n $ \u00a0 3,362<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 3,297<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 2.0<\/span>\n <\/p>\n<\/td>\n

\n

\n %<\/span>\n <\/p>\n<\/td>\n

\n

\n 2.0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n –<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n \u00a0\u00a0\u00a0 International<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 1,984<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,739<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 14.1<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 6.3<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 7.8<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 3,916<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 3,624<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 8.1<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 3.3<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 4.8<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n

\n
\n 3,735<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 3,296<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 13.3<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 9.2<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 4.1<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 7,278<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 6,921<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 5.2<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 2.7<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 2.5<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n Pharmaceutical<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n \u00a0\u00a0\u00a0 U.S.<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 6,869<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 6,120<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 12.2<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 12.2<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 13,315<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 12,181<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 9.3<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 9.3<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n –<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n \u00a0\u00a0\u00a0 International<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 5,730<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 4,632<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 23.7<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 15.4<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 8.3<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 11,483<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 9,705<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 18.3<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 11.4<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 6.9<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n

\n
\n 12,599<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 10,752<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 17.2<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 13.6<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 3.6<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 24,798<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 21,886<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 13.3<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 10.3<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 3.0<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n Medical Devices<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n \u00a0\u00a0\u00a0 U.S.<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 3,299<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,862<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 77.2<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 77.2<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 6,353<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 4,760<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 33.5<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 33.5<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n –<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n \u00a0\u00a0\u00a0 International<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 3,679<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 2,426<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 51.6<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 41.9<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 9.7<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 7,204<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 5,460<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 31.9<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 24.5<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 7.4<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n

\n
\n 6,978<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 4,288<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 62.7<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 57.2<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 5.5<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 13,557<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 10,220<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 32.7<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 28.7<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 4.0<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n U.S.<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 11,919<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 9,539<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 24.9<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 24.9<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 23,030<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 20,238<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 13.8<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 13.8<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n –<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n International<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 11,393<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 8,797<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 29.5<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 20.9<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 8.6<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 22,603<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 18,789<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 20.3<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 13.7<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 6.6<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Worldwide<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n $ 23,312<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 18,336<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 27.1<\/span>\n <\/p>\n<\/td>\n

\n

\n %<\/span>\n <\/p>\n<\/td>\n

\n

\n 23.0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 4.1<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n $ 45,633<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 39,027<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 16.9<\/span>\n <\/p>\n<\/td>\n

\n

\n %<\/span>\n <\/p>\n<\/td>\n

\n

\n 13.7<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 3.2<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n Note:Percentages have been calculated using actual, non-rounded figures and, therefore, may not recalculate precisely.\u00a0<\/b><\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

\u00a0<\/p>\n

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

\n
\n Johnson & Johnson and Subsidiaries<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n Supplementary Sales Data<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n (Unaudited; Dollars in Millions)<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n SECOND QUARTER<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n SIX MONTHS<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n Percent Change<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n Percent Change<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n

\n
\n 2021<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 2020<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n Total<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n Operations<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n Currency<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 2021<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 2020<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n Total<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n Operations<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n Currency<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Sales to customers by<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n geographic area<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n U.S.<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n $ 11,919<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 9,539<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 24.9<\/span>\n <\/p>\n<\/td>\n

\n

\n %<\/span>\n <\/p>\n<\/td>\n

\n

\n 24.9<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n $ 23,030<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 20,238<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 13.8<\/span>\n <\/p>\n<\/td>\n

\n

\n %<\/span>\n <\/p>\n<\/td>\n

\n

\n 13.8<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n –<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n Europe<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 5,668<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 4,063<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 39.5<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 28.6<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 10.9<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 11,082<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 8,890<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 24.7<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 15.6<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 9.1<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Western Hemisphere excluding U.S.<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 1,367<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,133<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 20.6<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 12.7<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 7.9<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 2,791<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 2,635<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 5.9<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 5.4<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 0.5<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Asia-Pacific, Africa<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 4,358<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 3,601<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 21.0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 14.8<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 6.2<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 8,730<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 7,264<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 20.2<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 14.2<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 6.0<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n International<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 11,393<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 8,797<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 29.5<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 20.9<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 8.6<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 22,603<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 18,789<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 20.3<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 13.7<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 6.6<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n Worldwide<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n $ 23,312<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 18,336<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 27.1<\/span>\n <\/p>\n<\/td>\n

\n

\n %<\/span>\n <\/p>\n<\/td>\n

\n

\n 23.0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 4.1<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n $ 45,633<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 39,027<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 16.9<\/span>\n <\/p>\n<\/td>\n

\n

\n %<\/span>\n <\/p>\n<\/td>\n

\n

\n 13.7<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 3.2<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n

\n
\n Note:Percentages have been calculated using actual, non-rounded figures and, therefore, may not recalculate precisely.<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

\u00a0<\/p>\n

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

\n
\n Johnson & Johnson and Subsidiaries<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n Condensed Consolidated Statement of Earnings\u00a0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n (Unaudited; in Millions Except Per Share Figures)<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n SECOND QUARTER<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n

\n
\n 2021<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 2020<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n Percent<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n Percent<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n Percent<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n Increase<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n

\n
\n Amount<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n to Sales<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n Amount<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n to Sales<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n (Decrease)<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Sales to customers<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n $ 23,312<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 100.0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n $ 18,336<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 100.0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 27.1<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Cost of products sold<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 7,587<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 32.5<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 6,579<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 35.9<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 15.3<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Gross Profit<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 15,725<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 67.5<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 11,757<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 64.1<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 33.8<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Selling, marketing and administrative expenses<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 6,073<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 26.1<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 4,993<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 27.2<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 21.6<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Research and development expense<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 3,394<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 14.6<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 2,707<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 14.8<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 25.4<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n In-process research and development<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 0.0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 6<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 0.0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n Interest (income) expense, net<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 28<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 0.1<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 26<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 0.2<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n Other (income) expense, net<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n (488)<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n (2.1)<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 24<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 0.1<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n Restructuring<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 56<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 0.2<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 61<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 0.3<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n Earnings before provision for taxes on income<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 6,662<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 28.6<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 3,940<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 21.5<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 69.1<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Provision for taxes on income<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 384<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1.7<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 314<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1.7<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 22.3<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Net earnings<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n $ \u00a0 6,278<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 26.9<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n $ \u00a0 3,626<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 19.8<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 73.1<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n Net earnings per share (Diluted)<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n $ \u00a0 \u00a0 2.35<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n $ \u00a0 \u00a0 1.36<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n 72.8<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n Average shares outstanding (Diluted)<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 2,671.6<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 2,665.5<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n Effective tax rate<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 5.8<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n %<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 8.0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n %<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n Adjusted earnings before provision for taxes and net earnings (1)<\/sup><\/b><\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n Earnings before provision for taxes on income<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n $ \u00a0 7,776<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 33.4<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n $ \u00a0 5,337<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 29.1<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 45.7<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Net earnings<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n $ \u00a0 6,625<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 28.4<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n $ \u00a0 4,446<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 24.2<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 49.0<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Net earnings per share (Diluted)<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n $ \u00a0 \u00a0 2.48<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n $ \u00a0 \u00a0 1.67<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n 48.5<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Effective tax rate<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 14.8<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n %<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 16.7<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n %<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n (1)<\/sup>See Reconciliation of Non-GAAP Financial Measures.<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n<\/table><\/div>\n

\u00a0<\/p>\n

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

\n
\n Johnson & Johnson and Subsidiaries<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n Condensed Consolidated Statement of Earnings\u00a0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n (Unaudited; in Millions Except Per Share Figures)<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n SIX MONTHS<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n

\n
\n 2021<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 2020<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n Percent<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n Percent<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n Percent<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n Increase<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n

\n
\n Amount<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n to Sales<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n Amount<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n to Sales<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n (Decrease)<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Sales to customers<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n $ 45,633<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 100.0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n $ 39,027<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 100.0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 16.9<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Cost of products sold<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 14,650<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 32.1<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 13,641<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 35.0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 7.4<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Gross Profit<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 30,983<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 67.9<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 25,386<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 65.0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 22.0<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Selling, marketing and administrative expenses<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 11,505<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 25.2<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 10,196<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 26.1<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 12.8<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Research and development expense<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 6,572<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 14.4<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 5,287<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 13.5<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 24.3<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n In-process research and development<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 0.0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 6<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 0.0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n Interest (income) expense, net<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 76<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 0.2<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n (16)<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 0.0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n Other (income) expense, net<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n (1,370)<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n (3.0)<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n (655)<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n (1.7)<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n Restructuring<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 109<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 0.2<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 119<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 0.3<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n Earnings before provision for taxes on income<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 14,091<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 30.9<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 10,449<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 26.8<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 34.9<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Provision for taxes on income<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 1,616<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 3.6<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,027<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 2.7<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 57.4<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Net earnings<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n $ 12,475<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 27.3<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n $ \u00a0 9,422<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 24.1<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 32.4<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n Net earnings per share (Diluted)<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n $ \u00a0 \u00a0 4.67<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n $ \u00a0 \u00a0 3.53<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n 32.3<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n Average shares outstanding (Diluted)<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 2,674.0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 2,671.0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n Effective tax rate<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 11.5<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n %<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 9.8<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n %<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n Adjusted earnings before provision for taxes and net earnings (1)<\/sup><\/b><\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n Earnings before provision for taxes on income<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n $ 16,067<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 35.2<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n $ 12,581<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 32.2<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 27.7<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Net earnings<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n $ 13,549<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 29.7<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n $ 10,600<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 27.2<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 27.8<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Net earnings per share (Diluted)<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n $ \u00a0 \u00a0 5.07<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n $ \u00a0 \u00a0 3.97<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n 27.7<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Effective tax rate<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 15.7<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n %<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 15.7<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n %<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n (1)<\/sup>See Reconciliation of Non-GAAP Financial Measures.<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n<\/table><\/div>\n

\u00a0<\/p>\n

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

\n
\n Johnson & Johnson and Subsidiaries<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n Reconciliation of Non-GAAP Financial Measures\u00a0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n Second Quarter<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n Six Months Ended<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n

\n (Dollars in Millions Except Per Share Data)<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 2021<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 2020<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 2021<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 2020<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n

\n Net Earnings, after tax- as reported<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n $6,278<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n $3,626<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n $12,475<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n $9,422<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n

\n
\n Pre-tax Adjustments\u00a0<\/i>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n

\n Intangible Asset Amortization expense<\/span>\n <\/p>\n<\/td>\n

\n

\n 1,202<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 1,127<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 2,417<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 2,245<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n

\n Litigation related<\/span>\n <\/p>\n<\/td>\n

\n

\n (23)<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 613<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n (23)<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 733<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n

\n IPR&D<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 6<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 6<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n

\n Restructuring related<\/span>\n <\/p>\n<\/td>\n

\n

\n 108<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 115<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 212<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 233<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n

\n Acquisition, integration and divestiture related \u00b9<\/span>\n <\/p>\n<\/td>\n

\n

\n 14<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 29<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n (524)<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n (933)<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n

\n Unrealized (gains)\/losses on securities\u00a0<\/span>\n <\/p>\n<\/td>\n

\n

\n (243)<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n (533)<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n (208)<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n (206)<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n

\n Medical Device Regulation<\/span>\n <\/p>\n<\/td>\n

\n

\n 56<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 37<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 102<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 51<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n

\n Other<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 3<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 3<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n

\n
\n Tax Adjustments<\/i>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n

\n Tax impact on special item adjustments 2<\/sup><\/span>\n <\/p>\n<\/td>\n

\n

\n (135)<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n (253)<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n (248)<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n (520)<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n

\n Tax legislation and other tax related<\/span>\n <\/p>\n<\/td>\n

\n

\n (632)<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n (324)<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n (654)<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n (434)<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n

\n Adjusted Net Earnings, after tax<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n $6,625<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n $4,446<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n $13,549<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n $10,600<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n

\n Average shares outstanding (Diluted)<\/span>\n <\/p>\n<\/td>\n

\n

\n 2,671.6<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 2,665.5<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 2,674.0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 2,671.0<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n

\n Adjusted net earnings per share (Diluted)<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n $2.48<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n $1.67<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n $5.07<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n $3.97<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n

\n Operational adjusted net earnings per share (Diluted)<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n $2.42<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n $4.91<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n

\n
\n Notes:<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n 1<\/sup>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n Acquisition, integration and divestiture related for the six months of 2021 primarily includes the gain on the divestiture of two Pharmaceutical brands outside of the U.S.\u00a0 The six months of 2020 primarily includes a $983M Contingent Consideration reversal related to the timing of certain developmental milestones associated with the Auris Health acquisition.\u00a0<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n
\n
\n 2<\/sup>
\n <\/span>
\n <\/sup>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n The tax impact related to special item adjustments reflects the current and deferred income taxes associated with the above pre-tax special items in arriving at adjusted earnings.<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n<\/tr>\n<\/table><\/div>\n

\u00a0<\/p>\n

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

\n
\n Johnson & Johnson and Subsidiaries<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n Reconciliation of Non-GAAP Financial Measure<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n
\n Adjusted Operational Sales Growth<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n \u00a0SECOND QUARTER 2021 ACTUAL vs. 2020 ACTUAL\u00a0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n \u00a0Segments\u00a0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n Consumer Health<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n \u00a0Pharmaceutical\u00a0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n \u00a0Medical Devices\u00a0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n \u00a0Total\u00a0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n \u00a0WW As Reported\u00a0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 13.3%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 17.2%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 62.7%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 27.1%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n \u00a0U.S.\u00a0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 12.4%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 12.2%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 77.2%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 24.9%<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n \u00a0International\u00a0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 14.1%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 23.7%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 51.6%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 29.5%<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n \u00a0WW Currency\u00a0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 4.1<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 3.6<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 5.5<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 4.1<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n \u00a0U.S.\u00a0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n –<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n –<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n –<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n –<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n \u00a0International\u00a0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 7.8<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 8.3<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 9.7<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 8.6<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n \u00a0WW Operational\u00a0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 9.2%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 13.6%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 57.2%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 23.0%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n \u00a0U.S.\u00a0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 12.4%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 12.2%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 77.2%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 24.9%<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n \u00a0International\u00a0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 6.3%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 15.4%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 41.9%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 20.9%<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n General Surgery<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n
\n Advanced Sterilization Products<\/i>
\n <\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1.2<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 0.2<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n \u00a0U.S.\u00a0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n 0.0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 0.0<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n \u00a0International\u00a0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n 1.9<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 0.4<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n All Other Acquisitions and Divestitures<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 0.8<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 0.6<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 0.3<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 0.6<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n \u00a0U.S.\u00a0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 0.6<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n (0.1)<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 0.7<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 0.1<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n \u00a0International\u00a0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 1.1<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 1.5<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 0.0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 1.0<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n WW Adjusted Operational<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 10.0%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 14.1%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 58.7%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 23.8%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n \u00a0U.S.\u00a0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 13.0%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 12.1%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 77.9%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 25.1%<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n \u00a0International\u00a0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 7.4%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 16.8%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 43.8%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 22.4%<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n Note: Percentages are based on actual, non-rounded figures and may not sum<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n<\/table><\/div>\n

\u00a0<\/p>\n

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

\n
\n Johnson & Johnson and Subsidiaries<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n Reconciliation of Non-GAAP Financial Measure<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n
\n Adjusted Operational Sales Growth<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n \u00a0SIX MONTHS 2021 ACTUAL vs. 2020 ACTUAL\u00a0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n \u00a0Segments\u00a0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n Consumer Health<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n \u00a0Pharmaceutical\u00a0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n \u00a0Medical Devices\u00a0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n \u00a0Total\u00a0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n \u00a0WW As Reported\u00a0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 5.2%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 13.3%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 32.7%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 16.9%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n \u00a0U.S.\u00a0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 2.0%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 9.3%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 33.5%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 13.8%<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n \u00a0International\u00a0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 8.1%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 18.3%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 31.9%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 20.3%<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n \u00a0WW Currency\u00a0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 2.5<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 3.0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 4.0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 3.2<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n \u00a0U.S.\u00a0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n –<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n –<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n –<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n –<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n \u00a0International\u00a0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 4.8<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 6.9<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 7.4<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 6.6<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n \u00a0WW Operational\u00a0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 2.7%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 10.3%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 28.7%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 13.7%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n \u00a0U.S.\u00a0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 2.0%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 9.3%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 33.5%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 13.8%<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n \u00a0International\u00a0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 3.3%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 11.4%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 24.5%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 13.7%<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n General Surgery<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n
\n Advanced Sterilization Products<\/i>
\n <\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 0.8<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 0.2<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n \u00a0U.S.\u00a0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n 0.0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 0.0<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n \u00a0International\u00a0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n 1.5<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 0.4<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n All Other Acquisitions and Divestitures<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 0.6<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 0.5<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 0.2<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 0.4<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n \u00a0U.S.\u00a0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 0.5<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n (0.1)<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 0.5<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 0.1<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n \u00a0International\u00a0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 0.7<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 1.2<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 0.0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 0.8<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n WW Adjusted Operational<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 3.3%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 10.7%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 29.7%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 14.4%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n \u00a0U.S.\u00a0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 2.5%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 9.2%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 33.9%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 13.9%<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n \u00a0International\u00a0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 4.0%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 12.6%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 26.0%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n 14.8%<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n Note<\/b>: Percentages are based on actual, non-rounded figures and may not sum<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n<\/table><\/div>\n

\u00a0<\/p>\n

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n
\n
\n REPORTED SALES vs. PRIOR PERIOD ($MM)<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n

\n
\n
\n
\n REPORTED SALES vs. PRIOR PERIOD ($MM)<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n

\n
\n SECOND QUARTER<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n

\n
\n SIX MONTHS<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n % Change<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n % Change<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n
\n 2021<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n
\n 2020<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Reported<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Operational (1)<\/sup><\/b><\/u><\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Currency<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n
\n 2021<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n
\n 2020<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Reported<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Operational (1)<\/sup><\/b><\/u><\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Currency<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n
\n CONSUMER HEALTH SEGMENT (2)\u00a0<\/sup><\/b><\/u><\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n OTC<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n $ \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 675<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 627<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 7.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 7.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n $ \u00a0 \u00a0 \u00a0 \u00a0 \u00a01,274<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,316<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -3.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n -3.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 633<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 522<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 21.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 10.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n 10.8%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,208<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,181<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 2.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n -4.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 7.0%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,307<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,149<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 13.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 8.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 4.9%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 2,482<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 2,497<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -0.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n -3.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 3.3%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n SKIN HEALTH \/ BEAUTY<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 659<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 536<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 23.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 23.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,293<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,195<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 8.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 8.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 511<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 471<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 8.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n 1.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n 7.0%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,040<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 929<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 12.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 6.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 5.2%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,170<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,007<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 16.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 12.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 3.3%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 2,333<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 2,124<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 9.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 7.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 2.2%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n ORAL CARE<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 165<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 170<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -3.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n -3.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 328<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 346<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -5.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n -5.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 260<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 227<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 14.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 6.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 7.9%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 514<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 446<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 15.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 10.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 5.1%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 426<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 397<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 7.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 2.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 4.5%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 843<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 792<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 6.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 3.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 2.8%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n BABY CARE<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 97<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 96<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 0.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 0.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 193<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 188<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 2.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n 2.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 290<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 260<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 11.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 6.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 4.9%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 583<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 529<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 10.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 9.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 1.2%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 387<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 356<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 8.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 5.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 3.6%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 776<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 717<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 8.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 7.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 0.8%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n WOMEN’S HEALTH<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 3<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 3<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -3.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n -3.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 6<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 7<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -16.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n -16.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 227<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 199<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 14.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 9.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 5.0%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 446<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 427<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 4.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 3.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 1.4%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 230<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 202<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 13.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 9.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 4.9%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 452<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 434<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 4.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 2.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 1.4%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n WOUND CARE \/ OTHER<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 153<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 126<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 20.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 20.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 268<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 245<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 9.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 9.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 64<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 59<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 7.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n -2.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 10.1%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 125<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 111<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 12.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 5.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 6.9%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 216<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 185<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 16.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 13.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n 3.2%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 393<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 356<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 10.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 8.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 2.2%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n
\n TOTAL CONSUMER HEALTH<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n US<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,751<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,557<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 12.4%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 12.4%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n –<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 3,362<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 3,297<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 2.0%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 2.0%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n –<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n Intl<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,984<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,739<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 14.1%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 6.3%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 7.8%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 3,916<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 3,624<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 8.1%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 3.3%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 4.8%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n WW<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n $ \u00a0 \u00a0 \u00a0 \u00a0 \u00a03,735<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 3,296<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 13.3%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 9.2%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 4.1%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n $ \u00a0 \u00a0 \u00a0 \u00a0 \u00a07,278<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 6,921<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 5.2%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 2.7%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 2.5%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n See footnotes at end of schedule<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n<\/table><\/div>\n

\u00a0<\/p>\n

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n \n <\/td>\n\n

\n

\n
\n
\n REPORTED SALES vs. PRIOR PERIOD ($MM)<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n

\n
\n
\n REPORTED SALES vs. PRIOR PERIOD ($MM)<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n

\n
\n SECOND QUARTER<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n

\n

\n
\n SIX MONTHS<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n % Change<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n % Change<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n
\n PHARMACEUTICAL SEGMENT (2,3)<\/sup><\/b><\/u><\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n
\n 2021<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n
\n 2020<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Reported<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Operational (1)<\/sup><\/b><\/u><\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Currency<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n
\n 2021<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n
\n 2020<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Reported<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Operational (1)<\/sup><\/b><\/u><\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Currency<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n
\n IMMUNOLOGY<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n $ \u00a0 \u00a0 \u00a0 \u00a0 \u00a02,748<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 2,362<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 16.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n 16.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n $ \u00a0 \u00a0 \u00a0 \u00a0 \u00a05,161<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 4,772<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 8.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 8.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,483<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,161<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 27.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 18.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 9.5%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 2,984<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 2,389<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 24.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 17.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 7.9%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 4,231<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 3,523<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 20.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 17.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 3.1%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 8,145<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 7,161<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 13.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 11.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 2.6%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n REMICADE<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US\u00a0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 540<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 593<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -9.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n -9.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,029<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,218<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -15.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n -15.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n US Exports (4)<\/sup><\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 93<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 133<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -30.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n -30.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 150<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 243<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -38.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n -38.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 255<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 208<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 22.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n 11.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 11.3%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 487<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 464<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 4.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n -1.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 6.6%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 888<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 935<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -5.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n -7.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 2.5%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,665<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,925<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -13.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n -15.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 1.6%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n SIMPONI \/ SIMPONI ARIA<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 290<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 256<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 12.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 12.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 545<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 528<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 3.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 3.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 294<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 289<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 1.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n -3.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 5.5%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 601<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 547<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 9.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 4.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 5.3%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 584<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 546<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 6.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 4.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 2.9%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,146<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,075<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 6.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 3.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 2.8%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n STELARA<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,496<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,138<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 31.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n 31.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 2,827<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 2,355<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 20.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 20.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 778<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 558<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 39.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 28.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 10.6%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,595<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,161<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 37.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 28.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 9.2%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 2,274<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,697<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 34.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 30.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 3.5%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 4,422<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 3,516<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 25.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 22.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 3.1%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n TREMFYA<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 325<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 241<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 35.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 35.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 599<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 428<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 40.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 40.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 155<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 101<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 52.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 41.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 11.2%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 298<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 210<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 41.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 31.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 10.0%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 479<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 342<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 40.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 36.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 3.4%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 897<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 638<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 40.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 37.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 3.3%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n OTHER IMMUNOLOGY<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 5<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n –<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 12<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n –<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 3<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -61.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n -67.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 6.6%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 3<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 6<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -51.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n -53.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 2.7%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 7<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 3<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 15<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 6<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n
\n INFECTIOUS DISEASES<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 444<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 416<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 6.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 6.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 956<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 852<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 12.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 12.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 585<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 463<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 26.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 18.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 8.1%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,079<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 946<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 14.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 7.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 6.3%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,028<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 878<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 17.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 12.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 4.3%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 2,035<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,798<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 13.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 9.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 3.3%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n COVID-19 VACCINE<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 51<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n –<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 151<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n –<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 113<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n –<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 113<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n –<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 164<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n –<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 264<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n –<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n EDURANT \/ rilpivirine<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 9<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 10<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -9.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n -9.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 19<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 22<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -10.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n -10.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 253<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 246<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 2.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n -4.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 6.8%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 486<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 458<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 6.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n -1.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 7.7%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 262<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 256<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 2.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n -4.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 6.5%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 505<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 480<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 5.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n -2.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 7.3%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n PREZISTA \/ PREZCOBIX \/ REZOLSTA \/ SYMTUZA<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 368<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 379<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -3.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n -3.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 748<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 775<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -3.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n -3.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 137<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 130<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 5.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n -5.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 11.4%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 303<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 314<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -3.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n -8.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 5.0%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 505<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 510<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -1.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n -3.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 2.9%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,051<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,089<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -3.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n -5.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 1.5%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n OTHER INFECTIOUS DISEASES<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 16<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 25<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -36.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n -36.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 37<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 54<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -31.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n -31.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 81<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 87<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -6.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n -13.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n 7.2%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 177<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 174<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 1.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n -3.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 4.8%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 98<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 113<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -13.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n -18.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 5.5%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 215<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 229<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -6.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n -9.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 3.6%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n<\/table><\/div>\n

\u00a0<\/p>\n

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n
\n
\n REPORTED SALES vs. PRIOR PERIOD ($MM)<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n
\n
\n REPORTED SALES vs. PRIOR PERIOD ($MM)<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n

\n
\n SECOND QUARTER<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n

\n
\n
\n SIX MONTHS<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n % Change<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n % Change<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n
\n 2021<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n
\n 2020<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Reported<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Operational (1)<\/sup><\/b><\/u><\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Currency<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n
\n 2021<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n
\n 2020<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Reported<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Operational (1)<\/sup><\/b><\/u><\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Currency<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n
\n NEUROSCIENCE<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 842<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 778<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 8.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 8.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,613<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,526<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 5.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 5.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 967<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 809<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 19.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 13.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 6.5%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,916<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,719<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 11.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 6.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 5.2%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,808<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,587<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 13.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 10.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 3.3%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 3,529<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 3,245<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 8.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 6.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 2.7%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n CONCERTA \/ Methylphenidate<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 35<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 55<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -36.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n -36.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 82<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 107<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -23.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n -23.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 127<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 94<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 33.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 25.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 8.1%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 250<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 212<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 17.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 11.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 6.4%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 161<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 149<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 8.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 3.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 5.1%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 332<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 320<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 3.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n -0.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 4.2%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n INVEGA SUSTENNA \/ XEPLION \/
INVEGA TRINZA \/ TREVICTA<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 645<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 576<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 11.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 11.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,234<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,120<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 10.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 10.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 380<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 303<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 25.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 15.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 9.2%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 756<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 642<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 17.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 9.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 7.8%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,024<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 879<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 16.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n 13.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 3.1%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,989<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,762<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 12.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 10.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 2.8%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n RISPERDAL CONSTA<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 72<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 74<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -3.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n -3.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 139<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 150<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -7.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n -7.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 84<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 79<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 6.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n 0.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 6.2%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 173<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 173<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 0.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n -4.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 5.0%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 155<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 153<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 1.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n -1.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 3.2%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 312<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 323<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -3.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n -6.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 2.7%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n OTHER NEUROSCIENCE<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 91<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 75<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 20.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 20.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 158<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 150<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 5.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 5.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 377<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 331<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 13.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 10.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 3.8%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 738<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 691<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 6.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 4.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 2.4%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 468<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 406<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 15.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 12.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 3.1%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 896<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 841<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 6.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 4.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 2.0%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n
\n ONCOLOGY<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,462<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,181<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 23.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 23.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 2,839<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 2,356<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 20.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 20.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 2,073<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,609<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 28.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 19.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 9.0%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 4,266<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 3,448<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 23.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 16.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 7.5%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 3,535<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 2,791<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 26.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 21.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 5.2%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 7,105<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 5,804<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 22.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n 17.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 4.5%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n DARZALEX<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 770<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 492<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 56.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 56.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,461<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 955<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 53.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 53.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 663<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 409<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 62.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 50.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 11.8%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,337<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 883<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 51.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n 42.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 9.1%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,433<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 901<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 59.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 53.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 5.4%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 2,798<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,838<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 52.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 47.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 4.3%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n ERLEADA<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 193<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 136<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 41.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 41.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 364<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 255<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 42.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 42.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 109<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 33<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 199<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 57<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 302<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 170<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 77.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 73.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 3.9%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 563<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 313<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 80.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 76.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n 3.6%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n IMBRUVICA<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 454<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 447<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 1.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 1.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 898<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 879<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 2.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 2.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 662<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 502<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 31.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 22.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 9.8%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,342<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,101<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 21.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 14.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 7.7%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,116<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 949<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 17.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 12.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 5.2%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 2,241<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,980<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 13.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 8.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 4.3%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n ZYTIGA \/ abiraterone acetate<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 21<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 87<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -75.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n -75.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 71<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 226<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -68.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n -68.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 542<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 480<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 12.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 5.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n 7.4%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,130<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,032<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 9.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 2.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 7.0%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 563<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 568<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -0.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n -7.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 6.3%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,201<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,258<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -4.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n -10.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 5.8%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n OTHER ONCOLOGY<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 23<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 20<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 18.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 18.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 44<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 42<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 6.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 6.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 97<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 185<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -47.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n -49.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 2.4%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 258<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 375<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -31.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n -34.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 3.3%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 120<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 204<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -40.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n -43.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 2.1%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 302<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 416<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -27.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n -30.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 2.9%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n<\/table><\/div>\n

\u00a0<\/p>\n

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n \n <\/td>\n\n \n <\/td>\n\n

\n

\n
\n
\n REPORTED SALES vs. PRIOR PERIOD ($MM)<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n

\n
\n
\n REPORTED SALES vs. PRIOR PERIOD ($MM)<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n

\n
\n SECOND QUARTER<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n

\n

\n
\n SIX MONTHS<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n % Change<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n % Change<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n
\n 2021<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n
\n 2020<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Reported<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Operational (1)<\/sup><\/b><\/u><\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Currency<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n
\n 2021<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n
\n 2020<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Reported<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Operational (1)<\/sup><\/b><\/u><\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Currency<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n
\n PULMONARY HYPERTENSION<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 595<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 545<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 9.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 9.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,168<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,031<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 13.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 13.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 275<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 243<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 13.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 7.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 5.6%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 563<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 503<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 12.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 6.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 5.4%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 870<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 789<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 10.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n 8.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 1.7%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,731<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,534<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 12.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 11.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 1.8%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n OPSUMIT<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 290<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 256<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 13.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 13.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 562<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 485<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 15.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 15.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 172<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 150<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 14.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 9.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 5.9%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 351<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 310<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 13.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 7.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 5.5%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 463<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 406<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 14.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 11.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 2.2%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 913<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 795<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 14.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 12.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 2.1%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n UPTRAVI<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 268<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 254<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 6.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 6.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 527<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 466<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 13.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 13.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 45<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 28<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 54.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 42.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 12.0%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 91<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 66<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 36.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 27.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n 9.4%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 313<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 282<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 11.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 9.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 1.2%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 618<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 532<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 16.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 15.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 1.2%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n OTHER PULMONARY HYPERTENSION<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 36<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 37<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -2.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n -2.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 78<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 81<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -3.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n -3.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 59<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 64<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -8.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n -10.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 2.1%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 122<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 126<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -3.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n -6.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 2.8%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 95<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 101<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -6.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n -7.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 1.4%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 200<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 207<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -3.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n -5.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 1.7%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n
\n CARDIOVASCULAR \/ METABOLISM \/ OTHER<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 780<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 837<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -6.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n -6.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,579<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,643<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -3.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n -3.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 346<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 347<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -0.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n -8.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n 8.1%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 674<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 701<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -3.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n -9.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 6.1%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,126<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,184<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -5.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n -7.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 2.3%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 2,253<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 2,344<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -3.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n -5.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 1.8%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n XARELTO<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 569<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 559<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 1.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 1.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,158<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,086<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 6.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 6.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n –<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n –<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n –<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n –<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 569<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 559<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 1.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 1.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,158<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,086<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 6.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 6.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n INVOKANA \/ INVOKAMET<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 96<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 132<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -27.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n -27.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 183<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 249<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -26.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n -26.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 64<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 47<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 33.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 22.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 11.7%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 127<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 105<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 20.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 12.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 8.1%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 160<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 179<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -10.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n -14.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 3.1%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 310<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 354<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -12.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n -15.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 2.4%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n PROCRIT \/ EPREX<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 59<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 70<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -16.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n -16.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 121<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 146<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -17.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n -17.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 69<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 66<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 3.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n -4.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 8.2%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 133<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 145<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -8.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n -14.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 5.9%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 127<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 136<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -6.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n -10.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 4.0%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 254<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 291<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -12.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n -15.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 2.9%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n OTHER<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 57<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 78<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -26.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n -26.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 117<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 163<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -27.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n -27.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 214<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 234<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -8.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n -15.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 7.3%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 415<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 451<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -8.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n -13.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 5.6%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 271<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 312<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -13.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n -18.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n 5.4%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 532<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 614<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n -13.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n -17.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n 4.1%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n
\n TOTAL PHARMACEUTICAL<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n US<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 6,869<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 6,120<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 12.2%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 12.2%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n –<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 13,315<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 12,181<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 9.3%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 9.3%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n –<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n Intl<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 5,730<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 4,632<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 23.7%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 15.4%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 8.3%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 11,483<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 9,705<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 18.3%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 11.4%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 6.9%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n WW<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n $ \u00a0 \u00a0 \u00a0 \u00a012,599<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 10,752<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 17.2%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 13.6%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 3.6%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n $ \u00a0 \u00a0 \u00a0 \u00a024,798<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 21,886<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 13.3%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 10.3%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 3.0%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n See footnotes at end of schedule<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n<\/table><\/div>\n

\u00a0<\/p>\n

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n \n <\/td>\n\n

\n

\n
\n
\n REPORTED SALES vs. PRIOR PERIOD ($MM)<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n

\n
\n
\n REPORTED SALES vs. PRIOR PERIOD ($MM)<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n

\n
\n SECOND QUARTER<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n

\n
\n SIX MONTHS<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n % Change<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n % Change<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n
\n MEDICAL DEVICES SEGMENT (2)<\/sup><\/b><\/u><\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n
\n 2021<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n
\n 2020<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Reported<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Operational (1)<\/sup><\/b><\/u><\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Currency<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n
\n 2021<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n
\n 2020<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Reported<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Operational (1)<\/sup><\/b><\/u><\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Currency<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n
\n INTERVENTIONAL SOLUTIONS<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n $ \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 475<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 255<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 86.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 86.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 909<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 620<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 46.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 46.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 572<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 335<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 70.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 59.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 10.7%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,086<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 697<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 55.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 46.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n 9.3%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,046<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 590<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 77.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n 71.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 6.1%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,995<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,317<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 51.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 46.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 5.0%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n
\n ORTHOPAEDICS<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US\u00a0<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,323<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 869<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 52.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 52.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 2,572<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 2,119<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 21.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n 21.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 904<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 583<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 55.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 43.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 11.9%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,768<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,371<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 29.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 20.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 8.8%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 2,227<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,451<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 53.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n 48.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 4.8%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 4,340<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 3,489<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 24.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n 20.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 3.5%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n HIPS<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 234<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 137<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 70.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 70.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 444<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 343<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 29.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 29.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 159<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 88<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 78.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 64.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 14.3%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 305<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 220<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 38.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 28.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 9.7%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 392<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 226<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 73.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 68.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 5.6%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 749<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 563<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 33.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 29.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 3.8%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n KNEES<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 210<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 108<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 94.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 94.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 395<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 322<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 22.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 22.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 140<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 66<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n 95.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 16.8%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 272<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 196<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 39.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 29.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 9.7%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 350<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 174<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n 94.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 6.4%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 667<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 517<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 28.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 25.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 3.7%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n TRAUMA<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 447<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 354<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 26.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 26.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 897<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 761<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 17.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 17.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 263<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 198<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 32.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 22.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 10.0%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 545<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 445<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 22.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 14.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n 8.1%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 710<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 553<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 28.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n 24.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 3.6%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,443<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,207<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 19.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 16.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 3.1%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n SPINE, SPORTS & OTHER<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 433<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 270<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 60.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 60.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 836<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 693<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 20.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 20.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 343<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 230<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 49.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 37.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 11.1%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 646<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 510<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 26.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 18.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 8.7%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 776<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 499<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 55.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 50.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 5.1%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,482<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,202<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 23.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 19.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 3.6%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n<\/table><\/div>\n

\u00a0<\/p>\n

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n

\n

\n
\n
\n REPORTED SALES vs. PRIOR PERIOD ($MM)<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n

\n
\n
\n REPORTED SALES vs. PRIOR PERIOD ($MM)<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n

\n
\n SECOND QUARTER<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n

\n
\n SIX MONTHS<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n % Change<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n % Change<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n
\n 2021<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n
\n 2020<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Reported<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Operational (1)<\/sup><\/b><\/u><\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Currency<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n
\n 2021<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n
\n 2020<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Reported<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Operational (1)<\/sup><\/b><\/u><\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n Currency<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n
\n SURGERY<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,035<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 490<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,933<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,334<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 44.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 44.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,487<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,060<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 40.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 30.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 9.6%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 2,961<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 2,317<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 27.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 20.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n 7.4%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 2,522<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,551<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 62.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 56.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 6.6%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 4,894<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 3,651<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 34.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 29.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 4.7%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n ADVANCED<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 459<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 277<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 65.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n 65.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 864<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 658<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 31.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 31.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 708<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 498<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 42.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 32.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 9.7%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,421<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,065<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 33.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n 25.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 7.8%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,168<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 775<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 50.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 44.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 6.2%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 2,286<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,723<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 32.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 27.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 4.8%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n GENERAL<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 576<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 213<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,069<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 676<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 58.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 58.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 779<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 562<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 38.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 28.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 9.6%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,540<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,252<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 23.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 15.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 7.1%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,354<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 775<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 74.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 67.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 6.9%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 2,608<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,928<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 35.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 30.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 4.6%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n
\n VISION<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 467<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 248<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 88.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 88.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 939<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 687<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 36.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 36.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 716<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 447<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 60.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 53.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 6.3%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,389<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,075<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 29.2%<\/span>\n <\/p>\n<\/td>\n

\n

\n 24.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 4.6%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,183<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 695<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 70.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 66.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 4.1%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 2,328<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,762<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 32.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 29.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 2.8%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n CONTACT LENSES \/ OTHER<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 352<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 203<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 73.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 73.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 723<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 549<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 31.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 31.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 517<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 352<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 47.0%<\/span>\n <\/p>\n<\/td>\n

\n

\n 41.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 5.1%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,003<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 819<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 22.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 18.5%<\/span>\n <\/p>\n<\/td>\n

\n

\n 4.0%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 868<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 554<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 56.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 53.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n 3.3%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 1,725<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,368<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 26.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 23.7%<\/span>\n <\/p>\n<\/td>\n

\n

\n 2.4%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n SURGICAL<\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n US<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 115<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 45<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 216<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 138<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 56.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n 56.3%<\/span>\n <\/p>\n<\/td>\n

\n

\n –<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Intl<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 199<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 96<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n 97.1%<\/span>\n <\/p>\n<\/td>\n

\n

\n 10.6%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 386<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 256<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 50.9%<\/span>\n <\/p>\n<\/td>\n

\n

\n 44.4%<\/span>\n <\/p>\n<\/td>\n

\n

\n 6.5%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n WW<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 314<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 141<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n

\n *<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 602<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 394<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 52.8%<\/span>\n <\/p>\n<\/td>\n

\n

\n 48.6%<\/span>\n <\/p>\n<\/td>\n

\n

\n 4.2%<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n
\n TOTAL MEDICAL DEVICES<\/b>
\n <\/u>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n US<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 3,299<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 1,862<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 77.2%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 77.2%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n –<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 6,353<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 4,760<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 33.5%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 33.5%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n –<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n Intl<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 3,679<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 2,426<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 51.6%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 41.9%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 9.7%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n 7,204<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 5,460<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 31.9%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 24.5%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 7.4%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n
\n WW<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n $ \u00a0 \u00a0 \u00a0 \u00a0 \u00a06,978<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 4,288<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 62.7%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 57.2%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 5.5%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n

\n
\n $ \u00a0 \u00a0 \u00a0 \u00a013,557<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n

\n
\n 10,220<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 32.7%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 28.7%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 4.0%<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n Note: <\/b>Columns and rows within tables may not add due to rounding. Percentages have been calculated using actual, non-rounded figures and,
\u00a0therefore, may not recalculate precisely.<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n * Percentage greater than 100% or not meaningful<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n (1) Operational growth excludes the effect of translational currency<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n (2) Unaudited<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n (3) Certain prior year amounts have been reclassified to conform to current year product disclosures<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n (4) Reported as U.S. sales<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n<\/table><\/div>\n

\u00a0<\/p>\n

\n

\n
\n \"(PRNewsfoto\/Johnson
\n <\/a>\n <\/p>\n<\/p><\/div>\n

\u00a0<\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/johnson–johnson-reports-q2-2021-results-301338422.html<\/a><\/p>\n

SOURCE Johnson & Johnson<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

– Strong sales growth of 27.1% to $23.3 Billion in Second Quarter 2021 with operational growth of 23.0%* and adjusted operational growth of 23.8%* – EPS of $2.35 increased 72.8% in Second Quarter 2021 and adjusted EPS of $2.48 increased 48.5%* – Company increasing 2021 Full-Year guidance for sales and EPS PR Newswire NEW BRUNSWICK, N.J., July 21, 2021 \/PRNewswire\/ —\u00a0Johnson & Johnson (NYSE: JNJ) today announced results for second-quarter. “Our second-quarter results showcase Johnson & Johnson’s diversified portfolio, driven by strong sales and earnings growth across our Medical Device, Consumer Health and Pharmaceutical businesses,” said Alex Gorsky, Chairman and Chief Executive Officer. “I’m so proud of our 136,000 colleagues who remain focused on delivering our medicines and products to … <\/p>\n

Continue reading “Johnson & Johnson Reports Q2 2021 Results”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-515480","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nJohnson & Johnson Reports Q2 2021 Results - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/johnson-johnson-reports-q2-2021-results\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Johnson & Johnson Reports Q2 2021 Results - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"– Strong sales growth of 27.1% to $23.3 Billion in Second Quarter 2021 with operational growth of 23.0%* and adjusted operational growth of 23.8%* – EPS of $2.35 increased 72.8% in Second Quarter 2021 and adjusted EPS of $2.48 increased 48.5%* – Company increasing 2021 Full-Year guidance for sales and EPS PR Newswire NEW BRUNSWICK, N.J., July 21, 2021 \/PRNewswire\/ —\u00a0Johnson & Johnson (NYSE: JNJ) today announced results for second-quarter. “Our second-quarter results showcase Johnson & Johnson’s diversified portfolio, driven by strong sales and earnings growth across our Medical Device, Consumer Health and Pharmaceutical businesses,” said Alex Gorsky, Chairman and Chief Executive Officer. “I’m so proud of our 136,000 colleagues who remain focused on delivering our medicines and products to … Continue reading "Johnson & Johnson Reports Q2 2021 Results"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/johnson-johnson-reports-q2-2021-results\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-21T10:28:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/403394\/Johnson_and_Johnson_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"18 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/johnson-johnson-reports-q2-2021-results\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/johnson-johnson-reports-q2-2021-results\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Johnson & Johnson Reports Q2 2021 Results\",\"datePublished\":\"2021-07-21T10:28:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/johnson-johnson-reports-q2-2021-results\\\/\"},\"wordCount\":3526,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/johnson-johnson-reports-q2-2021-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/403394\\\/Johnson_and_Johnson_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/johnson-johnson-reports-q2-2021-results\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/johnson-johnson-reports-q2-2021-results\\\/\",\"name\":\"Johnson & Johnson Reports Q2 2021 Results - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/johnson-johnson-reports-q2-2021-results\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/johnson-johnson-reports-q2-2021-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/403394\\\/Johnson_and_Johnson_Logo.jpg\",\"datePublished\":\"2021-07-21T10:28:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/johnson-johnson-reports-q2-2021-results\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/johnson-johnson-reports-q2-2021-results\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/johnson-johnson-reports-q2-2021-results\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/403394\\\/Johnson_and_Johnson_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/403394\\\/Johnson_and_Johnson_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/johnson-johnson-reports-q2-2021-results\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Johnson & Johnson Reports Q2 2021 Results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Johnson & Johnson Reports Q2 2021 Results - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/johnson-johnson-reports-q2-2021-results\/","og_locale":"en_US","og_type":"article","og_title":"Johnson & Johnson Reports Q2 2021 Results - Market Newsdesk","og_description":"– Strong sales growth of 27.1% to $23.3 Billion in Second Quarter 2021 with operational growth of 23.0%* and adjusted operational growth of 23.8%* – EPS of $2.35 increased 72.8% in Second Quarter 2021 and adjusted EPS of $2.48 increased 48.5%* – Company increasing 2021 Full-Year guidance for sales and EPS PR Newswire NEW BRUNSWICK, N.J., July 21, 2021 \/PRNewswire\/ —\u00a0Johnson & Johnson (NYSE: JNJ) today announced results for second-quarter. “Our second-quarter results showcase Johnson & Johnson’s diversified portfolio, driven by strong sales and earnings growth across our Medical Device, Consumer Health and Pharmaceutical businesses,” said Alex Gorsky, Chairman and Chief Executive Officer. “I’m so proud of our 136,000 colleagues who remain focused on delivering our medicines and products to … Continue reading \"Johnson & Johnson Reports Q2 2021 Results\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/johnson-johnson-reports-q2-2021-results\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-21T10:28:15+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/403394\/Johnson_and_Johnson_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"18 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/johnson-johnson-reports-q2-2021-results\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/johnson-johnson-reports-q2-2021-results\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Johnson & Johnson Reports Q2 2021 Results","datePublished":"2021-07-21T10:28:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/johnson-johnson-reports-q2-2021-results\/"},"wordCount":3526,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/johnson-johnson-reports-q2-2021-results\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/403394\/Johnson_and_Johnson_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/johnson-johnson-reports-q2-2021-results\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/johnson-johnson-reports-q2-2021-results\/","name":"Johnson & Johnson Reports Q2 2021 Results - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/johnson-johnson-reports-q2-2021-results\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/johnson-johnson-reports-q2-2021-results\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/403394\/Johnson_and_Johnson_Logo.jpg","datePublished":"2021-07-21T10:28:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/johnson-johnson-reports-q2-2021-results\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/johnson-johnson-reports-q2-2021-results\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/johnson-johnson-reports-q2-2021-results\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/403394\/Johnson_and_Johnson_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/403394\/Johnson_and_Johnson_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/johnson-johnson-reports-q2-2021-results\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Johnson & Johnson Reports Q2 2021 Results"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/515480","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=515480"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/515480\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=515480"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=515480"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=515480"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}